Markets:

Overview

News

Currencies

International

Treasuries

Horizon Therapeutics Public Limited Company - Ordinary Shares (NQ:HZNP)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 5, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Horizon Therapeutics Public Limited Company - Ordinary Shares

3 Stocks to Buy Low Today With High Hopes for Tomorrow ↗

April 15, 2024

Amgen, Canadian Solar, and Diana Shipping are three undervalued stocks with high potential for growth that can enhance portfolio returns.

Via InvestorPlace

Peering Into Horizon Therapeutics's Recent Short Interest ↗

October 05, 2023

Via Benzinga

Here's How Much $100 Invested In Horizon Therapeutics 5 Years Ago Would Be Worth Today ↗

October 04, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 28, 2023

Via Benzinga

How Is The Market Feeling About Horizon Therapeutics? ↗

September 18, 2023

Via Benzinga

These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts ↗

September 13, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

$1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth This Much Today ↗

September 12, 2023

Via Benzinga

Here's How Much $1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today ↗

September 04, 2023

Via Benzinga

The 3 Most Undervalued Biotech Stocks to Buy in September 2023 ↗

September 12, 2023

While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 11, 2023

Via Benzinga

Amgen's Horizon Acquisition Offers Multiple Advantages: Tax Breaks, Shield From Drug Pricing Negotiations ↗

September 05, 2023

On Friday, the U.S.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 05, 2023

Via Benzinga

This Is What Whales Are Betting On Horizon Therapeutics ↗

September 01, 2023

Via Benzinga

Peering Into Horizon Therapeutics's Recent Short Interest ↗

August 31, 2023

Via Benzinga

P/E Ratio Insights for Horizon Therapeutics ↗

August 30, 2023

Via Benzinga

Is Amgen Stock a Top Buy and Hold? ↗

August 21, 2023

The biotech checks several important boxes for long-term shareholders.

Via The Motley Fool

Stock Market Rally Gains Momentum As Treasury Yields Slide; Tesla Unveils Model 3 Upgrade: Weekly Review ↗

September 01, 2023

Tesla unveiled an updated Model 3, but also slashed Model S, X prices.

Via Investor's Business Daily

Amgen-Horizon Therapeutics $28B Acquisition: Federal Trade Commission Gives Green Signal ↗

September 01, 2023

The U.S. Federal Trade Commission (FTC) has approved drug manufacturer Amgen Inc (NASDAQ: AMGN) to proceed with its $27.8 billion acquisition of Horizon Therapeutics Plc (NASDAQ: HZNP).

Via Benzinga

Amgen, Horizon Therapeutics Stocks Jump After FTC Clears Their $28 Billion Marriage ↗

September 01, 2023

The deal can now close in the fourth quarter.

Via Investor's Business Daily

Is This the Green Light Biotech Stocks Have Been Waiting For? ↗

August 31, 2023

It looks like the Federal Trade Commission will give up on its attempt to block Amgen's acquisition of Horizon Therapeutics.

Via The Motley Fool

Nasdaq, S&P 500 Futures Flatline Ahead Of JOLTS, House Price Data; Why This Analyst Recommends 'Buying Weakness Than Selling Rallies' ↗

August 29, 2023

Via Benzinga

Topics Stocks

Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories ↗

August 28, 2023

Reuters

Via Benzinga

US Stocks Seen Opening Firmer In New Week's 1st Session As Traders Look To Week's Key Data; Analyst Constructive Despite Bearish Signals ↗

August 28, 2023

Via Benzinga

FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal ↗

August 26, 2023

The Federal Trade Commission (FTC) decided to momentarily halt its challenge against pharmaceutical giant Amgen, Inc (NASDAQ: AMGN), concerning its proposed acquisition of Horizon Therapeutics PLC...

Via Benzinga

Horizon Therapeutics Jumps On A New FTC Development In The Amgen Takeover Battle ↗

August 25, 2023

The FTC is pulling back somewhat on its effort to challenge the deal.

Via Investor's Business Daily

Could Amgen Stock Help You Become a Millionaire? ↗

August 16, 2023

Its pending acquisition of Horizon Therapeutics could make the company much bigger.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 07, 2023

Via Benzinga

Amgen Beats Expectations, Raises Outlook With Horizon Takeover In The Wings ↗

August 03, 2023

The massive biotech company also beat second-quarter expectations Thursday.

Via Investor's Business Daily

Amgen To Report Q2 Earnings: Here's What To Expect ↗

July 31, 2023

Amgen will report second-quarter 2023 results on Aug. 3, after the market close.

Via Talk Markets

Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated ↗

July 28, 2023

Earlier today, Biogen Inc (NASDAQ: BIIB) agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.